Galapagos Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-20 11:09:29 ET
More on Galapagos
- Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation
- Galapagos meets primary goal in phase 3-enabling study for rare autoimmune disease asset
- Seeking Alpha’s Quant Rating on Galapagos
- Historical earnings data for Galapagos
- Financial information for Galapagos
Read the full article on Seeking Alpha
For further details see:
Galapagos Q4 2025 Earnings Preview
Galapagos NV
NASDAQ: GLPG
GLPG Trading
-1.93% G/L:
$32.80 Last:
71,213 Volume:
$32.66 Open:
GLPG Latest News
GLPG Stock Data
$2,234,899,163
48,533,193
0.1%
30
N/A
Biotechnology & Life Sciences
Healthcare
BE
Mechelen
